Considerations for Rigorous Pre-clinical Studies in Murine Muscular Dystrophy

ORIGINAL AIR DATE: WED, AUG 19, 2020

During this webinar three experts will present key considerations in the design of rigorous preclinical studies in rodent models of muscular dystrophy.  The presentation will include topics such as animal model selection, assays and endpoints, and how your results can inform translation to the clinic.

Key topics covered during this webinar include…

• Consideration when designing a pre-clinical efficacy study in rodent models of muscular dystrophy
• Choosing the most appropriate animal models, assays and endpoints
• How your results can inform the translation to the clinic

Speakers

Sharon Hesterlee, PhD

EVP, Chief Research Officer
Muscular Dystrophy Association

Chris Ward, PhD

Associate Professor, University of Maryland School of Medicine;
Chief Scientific Officer, Myologica

Ramzi Khairallah, PhD

Co-Founder & President
Myologica